dsip liquid PEPTIDE 2MG/5MG VIAL – UMBRELLA Labs DSIP Peptide – Research Quality

Treatment of DAN DAN is a serious complication of diabetes mellitus that affects the ANS, leading to dysfunction in multiple organ systems

For in vivo rodent research: BPC-157 : 10 g/kg/day subcutaneous or intraperitoneal, 2-4 weeks TB-500 : 2-3 mg cumulative over 2-3 injections per week, 4-6 weeks Stack : same independent doses, separate or combined injections Clinical human protocols have not yet been standardized the few phase I/II trials used doses empirically derived from animal models

Once BPC-157 is reconstituted, the conversion from a target dose to syringe units depends on the chosen dilution

Because peptides are naturally occurring in the body, side effects are rare

NAD+ is not a classic signaling peptide